Targeting mutant estrogen receptors

A drug used in hormone replacement therapy can target estrogen receptors that have become resistant to breast cancer treatments.

Bibliographic Details
Published in:	eLife
Main Authors:	Suzanne E Wardell, John D Norris, Donald P McDonnell
Format:	Article
Language:	English
Published:	eLife Sciences Publications Ltd 2019-01-01
Subjects:	breast cancer acquired drug resistance hormone therapy bazedoxifene estrogen receptor SERM/SERD
Online Access:	https://elifesciences.org/articles/44181

Internet